Most active investors · Last 30 days
Ranked by rounds participated in, from announcements in Sep 23, 2026 – Oct 22, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Namespace $42M Series BVolantis $88M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Reuse $21M Series AMojave Energy Systems $19M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Hestus, Inc. $7.4M SeedDaedal Systems $4M FundingDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Conway Research Undisclosed First financingBasecamp Research $140M Series CDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
FRANK Undisclosed UndisclosedUsawa Care $3M SeedDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
LAUNCHub Fund III €65M Fund first closeHeadline EU VIII $400M Venture capital fund final closeDetails
New companies 1 · Follow-on 1
Stages: Series B 1, Undisclosed 1
Armadin $255.5M Series BLocus Lock Undisclosed Strategic fundingDetails
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Homeward $120M Series DNscale $3.4B Pre-IPO convertible loan notesDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Headline EU VIII $400M Venture capital fund final closeEverphone €15M €15 million corporate loan refinancingDetails
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Homeward $120M Series DRiskScout Undisclosed UndisclosedDetails
Details
New companies 1 · Follow-on 1
Stages: Series A 1, Undisclosed 1
Volantis $88M Series AEfficient Computer $100M Additional fundingDetails
Details
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Varda $251M Series DNscale $3.4B Pre-IPO convertible loan notesDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Miter $40M Series BInstinct $1B Series CDetails
Details
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Tryp.com €1.9M €1.9 million funding roundTEKEVER $580M Series DDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Zenithon AI $10M SeedHubble Network $200M Series CDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Restate $20M Series ABasecamp Research $140M Series CDetails
New companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Kuro Technology €10M SeedReverion $175M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
CScale $145M Series CGeneral Intuition $220M UndisclosedDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
RiskScout Undisclosed UndisclosedCrux Analytics $2.2M SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Reco $55M Series B extensionBigHat Biosciences $75M Series CDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
BridgeSmile Co., Ltd. ¥819M Series ASmolt Co., Ltd. ~¥200M Pre-Series A extensionDetails
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.